scholarly journals Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells

Toxicology ◽  
2017 ◽  
Vol 392 ◽  
pp. 11-21 ◽  
Author(s):  
Zhen Ren ◽  
Si Chen ◽  
Tao Qing ◽  
Jiekun Xuan ◽  
Letha Couch ◽  
...  
Tumor Biology ◽  
2016 ◽  
Vol 37 (7) ◽  
pp. 9615-9624 ◽  
Author(s):  
Kyoung Ah Kang ◽  
Mei Jing Piao ◽  
Susara Ruwan Kumara Madduma Hewage ◽  
Yea Seong Ryu ◽  
Min Chang Oh ◽  
...  

Renal Failure ◽  
2015 ◽  
Vol 37 (5) ◽  
pp. 903-910 ◽  
Author(s):  
LieMei Zhang ◽  
Ling Ji ◽  
XiaoHong Tang ◽  
XiaoLei Chen ◽  
Zi Li ◽  
...  

2019 ◽  
Vol 9 (10) ◽  
pp. 273 ◽  
Author(s):  
Bin Xu ◽  
Li-Min Lang ◽  
Shuai Lian ◽  
Jing-Ru Guo ◽  
Jian-Fa Wang ◽  
...  

Chronic stress can damage homeostasis and induce various primary diseases. Although chronic cold stress is becoming an increasing problem for people who must work or live in extreme environments, risk-induced diseases in the central nervous system remain unstudied. Male C57BL/6 mice were exposed to an environment of 4 °C, 3 h per day for 1, 2, and 3 weeks and homeostasis in the hippocampus and neuronal apoptosis were evaluated by Western blotting, immunohistochemistry, TdT-mediated dUTP Nick-End Labeling (TUNEL) staining, and immunofluorescence. The phenomena of oxidation stress, MAPK signaling pathway activation, anti-oxidation protein release, neuronal apoptosis increases, and neuronal proliferation inhibition were demonstrated in the CA1 and CA3 regions of mouse hippocampal tissues following cold exposure. We speculated that these phenomena were mediated by the MAPK pathway and were closely linked with oxidative stress in the hippocampus. This study provides novel concepts regarding neurodegenerative diseases, suggesting that chronic cold stress may be a critical factor to induce neurodegenerative diseases.


PLoS ONE ◽  
2019 ◽  
Vol 14 (11) ◽  
pp. e0225066 ◽  
Author(s):  
Minori Kubota ◽  
Kazuki Kakimoto ◽  
Takatoshi Nakagawa ◽  
Eiko Koubayashi ◽  
Kei Nakazawa ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-9
Author(s):  
Xiong Wang ◽  
Run-zhu Guo ◽  
Li Ma ◽  
Qiao-yan Ding ◽  
Jun-hua Meng ◽  
...  

Prolactinomas are harmful to human health, and the clinical first-line treatment drug is bromocriptine. However, 20% prolactinomas patients did not respond to bromocriptine. Hordenine is an alkaloid separated from Fructus Hordei Germinatus, which showed significant antihyperprolactinemia activity in rats. The aim of this study was to explore the effect and mechanism of hordenine on prolactinomas in rats. The study used estradiol to induce prolactinomas, which caused the activation of the pituitary mitogen-activated protein kinase (MAPK) pathway in rats significantly. The treatment of hordenine restored estradiol, induced the overgrowth of pituitary gland, and reduced the prolactin (PRL) accumulation in the serum and pituitary gland of rats by blocking the MAPK (p38, ERK1/2, and JNK) activation and production of inflammatory cytokines, tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6). The antiprolactinoma effect of hordenine was mediated by inhibiting the MAPK signaling pathway activation in rats.


Sign in / Sign up

Export Citation Format

Share Document